PCN82 Cost-Effectiveness Analysis of Erlotinib Versus Platinum Based Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer EGFR Activating Mutations
P. Garrido, G. López-Vivanco, R. Rosell, B. Espinós, A. Castro-GomezVolume:
15
Year:
2012
Language:
english
DOI:
10.1016/j.jval.2012.08.2122
File:
PDF, 59 KB
english, 2012